The 2026 dyslipidemia guidelines offer “a chance to save lives at scale.” But statins alone can’t solve the problem.
Strait Access Technologies ( e-mail info@sat.za.com), a medical technology company developing next-generation cardiovascular ...
The study serves as a reminder of what can happen when disease progresses in asymptomatic patients, David Cohen says.
Absent contraindications, optimal medical therapy for heart failure with preserved ejection fraction (HFpEF) should include a ...
Experts hope the FAI score can become the next big tool in personalized risk assessment, though costs remain unknown.
The data provide context on the ongoing workforce shortage in heart failure, a pipeline puzzle that’s proving hard to solve.
The US Food and Drug Administration has approved enlicitide (Lipfendra) as the first oral PCSK9 inhibitor for reducing LDL ...
The pilot study provides “a good illustration of how AI can be an augmentation to our current processes,” Thomas Maddox says.
In a pivot from personal safety measures, the multisociety effort calls on stakeholders to pursue a modern, standardized ...
With expectations to work after hours and a growing administrative burden, some say “radical” action is needed.
In Part 2, Wayne Batchelor, Vinod Thourani, Megan Coylewright, Basel Ramlawi, Sammy Elmariah, and Tsuyoshi Kaneko discuss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results